Clinical Trial Update: Rigorous Assessment of P. Vivax Relapses and Primaquine Efficacy for Radical Cure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the efficacy of primaquine for radical cure of Plasmodium vivax malaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Vivax Malaria

Drugs mentioned

• Primaquine (primaquine)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Vivax Malaria | Phase 4 | Status: COMPLETED